Business
Eurofins Announces the Cancellation of 6.163M Repurchased Shares
LUXEMBOURG, April 01, 2026--Regulatory News: Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 6,163,000 shares, representing 3.38% of the Company’s share capital, that were repurchased as part of its share buyback programmes, which began in October 2022.
About this update from Eurofins Scientific Se
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1518,"height":299,"url":"https://media.zenfs.com/en/business-wire.com/9233cce556bf729b2ce47055f8ed8adf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/p__iH9k7oJGLIe7_rOFVCQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE4OQ--/https://media.zenfs.com/en/business-wire.com/9233cce556bf729b2ce47055f8ed8adf","width":960,"height":189},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/5X_VAUtGg5W5GeKc53BiiA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NzI-/https://media.zenfs.com/en/business-wire.com/9233cce556bf729b2ce47055f8ed8adf","width":1200,"height":236}},"lazy":false},{"type":"text","content":"LUXEMBOURG, April 01, 2026--(BUSINESS WIRE)--Regulatory News:","length":61,"tagName":"p"},{"type":"text","content":"Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 6,163,000 shares, representing 3.38% of the Company’s share capital, that were repurchased as part of its share buyback programmes, which began in October 2022.","length":328,"tagName":"p"},{"type":"text","content":"The cancellation of shares is in line with, among other objectives, the Company’s intention to reduce the share capital as authorised by shareholders at the Annual General Meeting held on 24 April 2025.","length":202,"tagName":"p"},{"type":"text","content":"Following this cancellation of repurchased shares, which is effective as of 31 March 2026, the total number of Eurofins shares outstanding is now 176,000,000.","length":158,"tagName":"p"},{"type":"text","content":"About Eurofins – the global leader in bio-analysis","length":50,"tagName":"p"},{"type":"text","content":"Eurofins is Testing for Life. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is also one of the market leaders in certain testing and laboratory services for genomics, and in the support of clinical studies, as well as in biopharma contract development and manufacturing. It also has a rapidly developing presence in highly specialised an...